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Ehlers-Danlos syndrome (EDS) is a group of inherited connective tissue disorders that result in 
joint hypermobility, skin fragility, and chronic pain.  Undiagnosed connective tissue disorder 
(UCTD) describes individuals who present with symptoms consistent with a connective tissue 
disorder, but do not have a confirmed clinical or genetic diagnosis.  A quantitative study was 
conducted to investigate the relationship between pain and quality of life (QOL) in individuals 
with EDS or UCTD.  The types of pain management techniques used and their reported 
effectiveness were also investigated.  Adults (n = 23) and children (n = 7) with EDS or UCTD 
completed questionnaires on pain (PQAS© for adults and PedsQLTM Pediatric Pain Questionnaire 
TM for children), quality of life (PedsQLTM Generic Core Scale) and pain management.  The 
results demonstrated that chronic pain is common, with variability in the type and frequency of 
pain experienced.  Increased pain is significantly related to decreased quality of life in the adult 
sample (p < 0.01).  The majority (85.7%) of the participants in this sample used pain 
management techniques and reported a wide variety of management types. In conclusion, the 
findings in the present study suggest that pain is common and may impact the QOL of 
individuals with EDS and UCTD.   The public health impact of this study is to increase 
awareness of EDS and UCTD and the difficulties in treating and managing these conditions.  
Future studies are warranted to determine which pain management techniques are most effective 
in improving QOL in EDS and UCTD. 
PAIN, PAIN MANAGEMENT, AND QUALITY OF LIFE IN EHLERS-DANLOS 
RELATED DISORDERS 
 
Tracy Anne Dawson, MS 
University of Pittsburgh, 2014 
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1.0  INTRODUCTION 
Connective tissue disorders (CTD) are a group of inherited conditions caused by mutations in 
genes encoding for elastin and collagen, which are two proteins in the body important for 
connective tissue development and structure.  There are many different types of connective tissue 
disorders that involve many different genes and have widely varying manifestations. 
Ehlers-Danlos syndrome  (EDS) is the most common CTD.  There are six different types 
of EDS that have variable clinical symptoms.  These symptoms can include issues of the skin, 
joints, blood vessels, and organs.  Undiagnosed connective tissue disorder (UCTD) are 
individuals who present with symptoms consistent with a connective tissue disorder, but do not 
have a confirmed clinical or genetic diagnosis.  There is a lot of overlap in CTD symptoms, so 
these individuals have not been classified in a particular type of CTD.  In many cases, those with 
UCTD have a suspected diagnosis of EDS, but have not been able to confirm the diagnosis with 
clinical criteria or genetic testing.  Many individuals with EDS and UCTD present with mild to 
severe pain.  The pain in EDS and UCTD is primarily characterized as musculoskeletal pain. 
This main goal of this study was to survey a population of individuals with these 
conditions to determine if there is a relationship between pain and quality of life (QOL).  This 
study also aims to determine if any other factor was associated with pain or quality of life in this 
sample.  This study hopes to also determine which pain management techniques these 
populations use and which techniques have been most successful.  The desired outcome is to 
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learn more information about the amount of pain experienced by these individuals, the effect the 
pain has on their quality of life, and the most effective pain management techniques. 
1.1 AIMS 
Aim 1: To characterize the types of pain experienced by individuals with EDS and UCTD.   
Aim 2: To determine the pain management techniques that EDS and UCTD patients use to 
relieve or reduce their pain, and determine which techniques they report to be the most effective. 
Aim 3: To assess the relationship between pain and quality of life in individuals with EDS and 
UCTD.  In the adult population, it is hypothesized that increased pain will be correlated with 
decreased quality of life in these participants.  
Aim 4: To investigate other factors that may relate to pain or quality of life in this sample, such 
as age, sex, or the use of pain management techniques.  It is hypothesized that age will be related 
to increased pain and decreased quality of life. 
1.2 BACKGROUND AND SIGNIFICANCE  
1.2.1 Connective Tissue in Humans and Connective Tissue Disorders 
In the human body, connective tissue acts as a structural support framework needed for growth, 
development, and protection of vital organs.  Types of connective tissue in the body are skin, 
tendons, ligaments, cartilage, and bone [1, 2].  Connective tissue interacts in a complex system 
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called the extracellular matrix (ECM), which consists of structural proteins (collagen and 
elastin), specialized proteins (fibrillin, fibronectin, and laminin), and proteoglycans [1, 2].  
Mutations of genes that encode for a protein involved in the ECM can result in a connective 
tissue disorder (CTD). 
1.2.2 Ehlers-Danlos Syndrome and Undiagnosed Connective Tissue Disorder 
Ehlers-Danlos Syndrome (EDS) is a group of heterogeneous inherited connective tissue 
disorders that primarily affects the skin, ligaments, joints, and blood vessels [2, 3].  EDS is one 
of the oldest known disorders of bruising and bleeding and was first described by Hippocrates in 
400 BC [4].  A Danish dermatologist named Edvard Ehlers first recognized EDS as a distinct 
disorder in 1901 and a French dermatologist named Henri-Alexandre Danlos suggested that the 
skin extensibility and fragility were also features of the same condition in 1908 [4]. An English 
physician named Frederick Parkes-Weber suggested the disorder be named ‘Ehlers-Danlos 
syndrome” in 1936 [4]. 
Table 1 Revised Classification of EDS Types 
Joint hypermobility, (JHM) [5] 
  Type Inheritance Gene Clinical Manifestations 
  Classical (EDS I and II) AD COL5A1 COL5A2 
Skin laxity, atrophic scars, JHM, hypotonia, 
hernias, velvety skin 
  Hypermobility (EDS III) AD TNX-B Skin laxity, JHM, frequent recurring joint dislocations, chronic joint pain 
  Vascular (EDS IV) AD COL3A1 Arterial/intestinal rupture, easy bruising, thin skin, varicose veins, JHM 
  Kyphoscoliosis (EDS VI) AR LH-1 Joint laxity, muscle hypotonia, kyphoscoliosis, sclera fragility 
  Arthrochalasis (EDS VIIA&B) AD COL1A1 COL1A2 
JHM, congenital hip dislocation, muscle 
hypotonia, kyphoscoliosis  
  Dermatosparaxis (EDS VIIC) AR ADAMTS-2 Sagging redundant skin, excessive bruising, severe skin fragility, soft/doughy skin 
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The current literature classifies EDS as a rare disease with a frequency between 1 in 
10,000 and 1 in 25,000 people, however EDS is thought to be a highly under diagnosed 
condition [3].  There are many types of EDS with different clinical features, inheritance patterns, 
and genetics, which are reviewed in Table 1 above.  The most common forms of EDS are EDS 
hypermobility type (EDS-HT), classic EDS, and vascular EDS [3].  The classic symptoms 
include hyperextensible skin, hypermobile joints, dystrophic scarring, fragile connective tissue, 
and easy bruising [2, 3, 5].  Skin is often velvety, thin, and easily splits with little or no trauma 
[2, 3].  Individuals with EDS can also have difficulty and delay in healing, which eventually lead 
to atrophic scars [2, 3].   EDS can also lead to frequent joint dislocations, especially in the hip, 
patella, shoulders, and hands [2, 3].   Due to the wide range of manifestations of this disorder, 
many aspects of an individual’s life can be affected including physical and psychologically [2, 
3].  Additional features include fatigue, anxiety, and depression which have been thought to be a 
result of the chronic and debilitating pain [6, 7]. 
There is some genetic testing for EDS that can be performed, however this testing does 
not identify a genetic cause for all individuals with a clinical EDS diagnosis.  Previous literature 
has indicated that of individuals that met all major criteria for Villefranche criteria for classic 
EDS, more than 90% had a COL5A1 or COL5A2 defect [8, 9].  Genetic testing for EDS-HT 
involves looking for mutations in the TNX gene, however no more than 10% of individuals with 
a clinical EDS-HT diagnosis have a mutation in this gene [10, 11].  This suggests that there are 
other genes or genetic loci involved in EDS. 
The variability in EDS results in misdiagnosis, delay to diagnosis, and never being 
diagnosed.  The variability in the clinical picture of this condition contributes to this problem 
[12].   The lack of a correct diagnosis has been shown to affect the functionality of these 
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individuals due to financial expenses, unnecessary medical testing, use of incorrect treatments, 
delay in appropriate management, and the progression of disease [6, 12].  Due to the difficulties 
in diagnoses, many individuals with EDS are not diagnosed until after childhood [13].   These 
complications demonstrate the need for more studies that include individuals with an UCTD and 
suspected EDS. 
1.2.3 Pain in EDS and UCTD 
Chronic pain is a common feature, but highly variable among individuals with EDS [12, 14, 15].  
Some studies have reported as much as 90% of individuals with classic EDS or EDS-HT 
reporting at least moderate pain with the duration of pain being at least one year [15, 16].  In  
Castori et al., individuals with EDS and EDS-HT from Italy reported increased chronic 
musculoskeletal pain and fatigue, however pain was more likely in individuals with EDS-HT and 
was associated with hypermobility and dislocations [6].  The locations most frequently affected 
are the shoulders, hands, and knees [15].  Many previous studies have been done that have 
described the many types of pain experienced in EDS-HT including: dislocations, arthralgias, 
back pain, myalgias/myofascial pain, compression neuropathy, peripheral neuropathy, headache 
disorders, and abdominal pain [14, 15, 17, 18]. Musculoskeletal pain is a very common feature in 
EDS-HT and is associated with regular analgesic use, joint hypermobility, dislocations, 
corrective surgery, and related to functional impairment [14, 15].  Pain is recognized as a major 
criteria of JHS and in the minor criteria of the Villefranche criteria revised nosology for EDS-HT 
[5, 19].    
There is limited information about the origin of pain in EDS.  It is thought to be caused 
by joint damage due to frequent dislocations or soft tissue injury, which is secondary to the 
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disease manifestations [15].  Interestingly, pain in EDS is not thought to be neuropathic in origin, 
however more than 30% of individuals with EDS report neuropathic pain [16, 18] . Little 
information is known about the origin of the pain in EDS. Joint hypermobility syndrome (JHS) is 
sometimes used interchangeably with EDS hypermobility type due to the chronic nature of their 
joint laxity, however these are now thought to be separate conditions that have similar features 
[19]. 
Arthralgias, back pain, and myalgias occur in 30% of children with JHS/EDS-HT, while 
more than 80% of adults over forty experience these manifestations [17].  Another issue that 
faces many individuals with EDS-HT is that they may not always meet the diagnostic criteria 
and there are different criteria to follow.  The Beighton score which tends to fall below 4/9 at a 
mean age of 33 years in JHS/EDS-HT even individuals with many and severe disease 
manifestations [17].  Due to these findings, it is thought that pediatric and younger patients that 
generally display greater joint mobility and less pain symptoms may have a greater chance of 
meeting the Villefranche criteria [17, 20].   The Beighton criteria seem to better fit adult patients 
who experience greater pain and musculoskeletal manifestations, but have lost some of the 
flexibility and hypermobility they once experienced in their childhood [17, 20].  It has been 
suggested that there should be a shift in a diagnostic criteria that would incorporate the age, sex, 
and clinical history of patient [20]. 
Previous studies have also shown the importance of differentiating between nociceptive 
and neuropathic pain to develop more efficient treatments for EDS patients [16].    Previous 
literature has described three separate stages of EDS in the natural history of the disease: 
hypermobility, pain, and stiffness, again suggesting that the pain is secondary to the already 
existing musculoskeletal problems associated with EDS [6, 16, 21].   The theory developed from 
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these studies is that treatments need to target patients during the first phase in order to prevent 
the pain and stiffness phases.   
Some studies have shown an association between hypermobility and dislocations, 
however they have not investigate the actual origin of pain in EDS [18, 21].  However, some 
studies have targeted the mechanisms behind the pain associated with EDS.   One study 
conducted by Vooermans et al. showed that axonal polyneuropathy occurs in various types of 
EDS.  In the participants, 60% had reduced sensation, 40% had some reduced distal muscle 
force, and 25% had reduced reflexes [22].  Nerve conduction studies were abnormal in 38% and 
criteria for axonal polyneuropathy was met in 13% of patients [22]. 
1.2.4 Pain and Quality of Life 
Pain is a factor that can substantially alter an individual’s quality of life [23, 24]. Quality of life 
(QOL) is a term generally accepted in the medical field, which defines a person’s overall 
wellbeing.  QOL is often used for populations, which experience chronic or disabling conditions, 
such as arthritis. 
The potential effect that EDS may have on a patient’s quality of life is rarely investigated 
by physicians or in the current literature [25].  EDS symptoms often go unrecognized for years 
and patients are affected not only by being symptomatic, but also by being dismissed by 
practitioners, relatives, and friends [12]. This suggests that EDS and the associated chronic pain, 
fatigue, and other neurological features likely representing major risk factors for disability [26, 
27]. 
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In a 2010 study by Voermans et al. of 273 individuals with EDS, pain was related to 
functional impairment in daily life [14].  In this study, pain severity was related to disability, 
which has been reported in prior populations [28] 
 
1.2.5 Pain Management and Treatment in EDS and UCTD 
The treatment and management for EDS-HT can be frustrating for both patients and healthcare 
providers due to the lack of long-term relief or effective treatments.  Unfortunately, JHM or 
EDS-HT are sometimes still considered to be a benign syndrome that may only be important 
when planning surgeries due to frequent complications [29]. 
 Some recent studies have focused on identifying possible treatment options for 
individuals with EDS and to eventually create guidelines for management.  Some examples of 
prevention strategies for pain in EDS are light aerobic fitness, weight control, stretching, strength 
exercises, and avoiding strenuous exercise [29].  Some examples of first-line treatments include: 
rest, stretching, joint manipulation, heat therapy, acupuncture, stretching, and physical therapy 
[29].  Suggested treatments for more severe pain are pain medication (non-steroidal anti-
inflammatory drugs, corticosteroids, opioids, muscle relaxants), surgery, join injections, and anti-
depressants [29].   In a 2010 study by Voermans et al., 89% of 273 individuals with a type of 
EDS used some type of pain medication, which was associated with chronic pain [14].  
The treatments for EDS vary widely.  However, accumulated evidence suggests the 
importance of increasing awareness of CTDs, especially EDS-HT, in order to identify 
preventive, therapeutic, and rehabilitative strategies to preserve function and quality of life in 
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these patients [29].  As was previously mentioned, the current thought is that an individual’s sex, 
age, and clinical manifestations should be taken into account when treating EDS [12, 17]. 
1.2.6 Significance 
This study aims to examine the relationship between pain and quality of life in individuals with 
EDS and UCTD.  This study also will investigate if sex, age, or the use of pain management 
techniques is associated with quality of life.  There have been some previous studies that have 
focused on the EDS population and quality of life.  However, these studies did not include 
individuals with UCTD or a suspected EDS diagnosis.  Also, there have been limited studies that 
have investigated the relationship between pain management use and quality of life, which could 
allow for a better understanding of the effectiveness of pain management in this population.  
Also, there is limited information in the previous literature about which pain management 
methods this population is actually using and which they believe to be most effective.  This 
could help to develop better pain management programs that use one or multiple techniques that 
best relieve pain in for individuals with EDS.  It is important that this population receive better 
medical treatment as many of them experience debilitating pain on a regular basis that can affect 
their daily lives.   
.  
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2.0  MATERIALS AND METHODS 
2.1 DATA COLLECTION 
2.1.1 Patient Population 
The patient population consisted of male and female patients that were evaluated by one of the 
physicians in the Department of Medical Genetics at the Children’s Hospital of Pittsburgh.  
Inclusion criteria were that participants had to be between the ages of eight and 80 and had to be 
diagnosed with EDS or EDS-like symptoms.  Exclusion criteria were any patients under the age 
of eight or over the age of 80 and anyone without one of these two diagnoses. 
2.1.2 Patient Recruitment 
Patients were recruited through the Department of Medical Genetics at the Children’s Hospital of 
Pittsburgh.  Any patient that had been evaluated by one of the physicians, given a diagnosis of 
EDS or undiagnosed connective tissue disorder, and between the ages of eight and 80 was 
eligible for this study.  Patients were evaluated at the Department of Medical Genetics in 
February 2014 or earlier. All recruitment was compliant with IRB protocol number 
PRO13080515 (Appendix A).  A genetic counseling intern and a genetic counselor recruited 
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patients by identifying patients that met criteria to participate and sending the survey materials to 
those individuals (Appendix B). 
2.1.3 Informed Consent 
Informed consent involved describing the aims of the research project, as well as the 
requirements to participate, the rights of the participants, and the risks and benefits associated 
with the study (Appendix C).  Since this study involved minimal risk, the consent form was sent 
to the participants with the survey materials for them to review at their convenience.  After 
reading the consent form, the participants provided a signature, printed name, and data on the last 
page of the consent form.  In participants under the age of 18, both the parent and child signed 
the consent form.  The consent form was sent back with the survey materials.  No surveys were 
obtained or included in the study without written consent by participants or their parents.  
2.1.4 Sample 
The total number of eligible participants was 125, which were all recruited through the 
Department of Medical Genetics at the Children’s Hospital of Pittsburgh.  Of the 125 surveys 
sent, 69 (55.2%) were sent to individuals over 18 and 56 (44.8%) were sent to those under the 
age of 18.  Of the adults, 55 (79.7%) surveys were sent to females and 14 (20.3%) were sent to 
males.  Of the children, 29 (51.8%) were sent to females and 27 (48.2%) were sent to males. 
Of 125 eligible participants, 30 (24%) returned the surveys by mail.  Of the 69 surveys 
sent to adults, 23 (33.3%) were returned.  Of the 55 surveys sent to children, 7 (12.5%) were 
returned.  Of the 55 female adults, 22 (40%) were returned.  Of the 14 male adults, one (7%) was 
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returned.  Of the 29 female children, 3 (10%) were returned.  Of the 27 male children, 4 (14.8%) 
were returned. 
2.1.5 Tools 
The PedsQL TM Pediatric Pain Questionnaire TM (PPQ TM), Pediatric Quality of Life Inventory 
(PedsQLTM), and Pain Quality Assessment Scale© (PQAS©) appeared to be the optimal 
instruments for the current to collect the desired data.  The last questionnaire was created to 
determine which specific pain management techniques were being used and which were the most 
effective.  All of the surveys are included in Appendix D. 
 
Pediatric Pain Questionnaire TM  
Pain for the participants under age 18 was assessed through the Pediatric Pain Questionnaire TM  
(PPQ TM)[30].  The PPQ TM is a patient self-reported and age-specific questionnaire.  The PPQ TM 
assesses the intensity and locations of pain.  It also examines more subjective characteristics of a 
patient’s pain and allows them to describe with an open-ended question. The PPQ TM includes a 
100 mm horizontal line or a visual analog scale.   The scale is a range that begins with a smiling 
cartoon face with “no hurt at all” or by “no pain, not hurting, no discomfort”.  The scale ends 
with a sad cartoon face and “hurting a whole lot” or by “severe pain, hurting a whole lot, very 
uncomfortable”.  The survey also included an outline of a human body and asks the subject to 
place an “X” on the drawing in every area that they were currently experiencing pain and to rank 
those areas, with one being the most painful.  PPQ TM has been shown in previous literature to be 
a reliable and valid tool to measure pediatric self-reported chronic pain intensity [30] 
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Pain Quality Assessment Scale© 
Pain in adults was assessed through the Pain Quality Assessment Scale© (PQAS©), which is a 
valid and reliable tool to assess pain quality [31, 32].  The PQAS© asks patients to rate their 
average pain intensity over the past week on a 0-10 numerical rating scale, with 0 = “No Pain” 
and 10 = “The most intense pain sensation”. 
 Pain quality was assessed using a composite of the 20 items.  Each item assesses a 
different quality of pain.  Of the 20 total items, 15 items can be used to three subscores for 
paroxysmal, surface, and deep pain.  There are individual items to assess surface pain severity, 
deep pain severity, and pain unpleasantness. The last item on the PQAS© asks participants to 
choose which of the three statements best describes their pain: variable, intermittent, or stable 
[31, 32]. 
 
Adult and Child Quality of Life  
QOL was assessed through the Pediatric Quality of Life Inventory (PedsQLTM) Generic Core 
Scales module 4.0 (English version) self-report questionnaire [33, 34].  The PedsQLTM assesses 
patient’s perceptions of generic health-related quality of life with chronic health conditions [33, 
34].   
The PedsQLTM uses a 23-item questionnaire using the 0-4 Likert scale.  Three versions 
were used: Adult (over 18), Teen (13-18), and Child (8 to 12).  Each participant was provided 
with the appropriate questionnaire for his or her age.  The PedsQLTM focuses on four domains of 
quality of life: Physical, Emotional, Social, and School/Work.  These domains generate a 
composite score to assess overall QOL. 
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The PedsQLTM is a valid and reliable tool with internal consistency reliability for total 
QOL (alpha = 0.88 child, 0.86 adult), physical QOL (alpha = 0.80 child, 0.76 adult), 
psychosocial QOL (alpha = 0.83 child, 0.83 adult), emotional QOL (alpha = 0.73 child, 0.71 
adult), social QOL (alpha = 0.71 child, 0.78 adult), and school/work QOL (alpha = 0.68 child, 
0.75 adult) [30, 33-35]. The average scores in healthy children were 83 for total QOL, 84.41 for 
physical QOL, 82.38 for psychosocial QOL, 80.86 for emotional QOL, 87.42 for social QOL, 
78.63 for school/work QOL [35]. The average scores in healthy adults were 78.18 for total QOL, 
86.25 for physical QOL, 73.87 for psychosocial QOL, 66.68 for emotional QOL, 85.48 for social 
QOL, 69.47 for school/work QOL [34]. 
 For ease of interpretation of the PedsQLTM, score items are reverse scored and linearly 
transformed from 0-4 to a 0-100 scale (0=100, 1=75, 2=50, 3=25, 4=0), meaning that higher 
scores closer to 100 indicates better quality of life.  A subscore of 0-100 can be calculated for 
each domain and score of 0-100 for the overall Total Scale Score.  The Physical Functioning 
subscale score is reported as the Physical Health Summary Score.  The Psychosocial Health 
Summary Score equals the sum of the items divided by the number of items answered on the 
Emotional, Social, and School/Work Functioning subscales.   The Total Scale Score is the 
average of all of the items.   For the purposes of this study, this survey will be referred to as the 
QOL survey. 
 
Pain Management Questionnaire 
The final tool used was a questionnaire to assess pain management techniques used by 
participants (Appendix D).  If the participant was under the age of 18, the parent was asked to 
assist their child in completing the survey. 
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The questionnaire consisted of two questions.  The first question asked the participants to 
report any pain management techniques that had helped to relieve or reduce their pain.  The 
possible responses included physical therapy, exercise, pain medication, none, or other.  If the 
participant answered other, they were asked to specify.  The second question asked the 
participants to report which pain management technique best relieved or reduce their pain. The 
possible responses included physical therapy, exercise, pain medication, none, or other.  If the 
participant answered other, they were asked to specify. 
The amount of pain management techniques reported was also collected by counting the 
number of techniques used by each subject.  The amount of techniques used may indicate that 
pain management techniques are not effective for an individual. 
2.1.6 Survey Distribution 
Survey distribution began in February 2014.  Surveys were sent to participants by mail. 
Participants were asked to return the surveys within two weeks of receiving the materials. 
2.1.7 Statistical Analyses 
For assessing demographic information, descriptive statistics and frequencies were used.  For 
continuous data, correlations and linear regressions were computed.  Statistical analysis was 
carried out using IBM SPSS Statistics version 22. 
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3.0  RESULTS 
3.1 DESCRIPTIVES 
3.1.1 Entire Sample 
Subjects were adults (n = 23) and children (n = 7) between the ages of 13 and 58 with 30 total 
participants.  The sample consists of males (n = 5) and females (n = 25) with an average age of 
27.27 (SD ± 12.7) years. All participants completed an age-appropriate QOL survey and the Pain 
Management questionnaire.  Sample characteristics including ranges, means, and standard 
deviations were calculated for age, QOL, and pain management amount (Table 2).   
The first set of variables was from the PedsQL QOL questionnaire.  The mean total QOL 
score was 52.39 (SD ± 18.43).  The mean scores for the subscales physical QOL and 
psychosocial QOL were 43.65 (SD ± 27.21) and 56.28 (SD ± 17.1) respectively.  The mean 
scores of the components of psychosocial QOL were 53.33 (SD ± 16.21) for emotional QOL, 
67.67 (SD ± 17.12) for social QOL, and 50.17 (SD ± 26.11) for school/work QOL.  
The total amount of pain management techniques used ranged from 0 to 8, with a mean 
of 3.2 (SD ± 2.27). 
 
 
  17 
 
Table 2: Descriptives for age, QOL and pain management amount in all subjects 
 
 M (SD) Range 
Age 27.27 (12.70) 13 - 58 
Total QOL 52.39 (18.43) 21.74 - 86.96 
      Physical QOL 43.65 (27.21) 0.13 – 100 
      Psychosocial QOL 56.28 (17.1) 23.33 - 90 
           Emotional QOL 53.33 (16.21) 20 - 85 
           Social QOL 67.67 (17.12) 20 - 100 
           School/Work QOL 50.17 (26.11) 0 - 90 
Pain Management Amount 3.2 (2.27) 0 - 8 
 
Sample frequencies were calculated for sex, diagnosis, and pain management use (Table 
3).  The sample population was 83.3% (n = 25) female and 16.7% (n = 5) male.  About 36.7% (n 
= 11) have a clinical diagnosis of EDS, while 63.3% (n = 19) have a suspected EDS diagnosis, 
thus labeled as UCTD.  Of this sample, 85.7% (n = 26) used some type of pain management.   
 
Table 3: Frequencies of sex, diagnosis, and pain management use in all subjects 
Sex 
       Female 83.3% (n = 25) 
       Male 16.7% (n = 5) 
Diagnosis 
       Clinical EDS Diagnosis 36.7% (n = 11) 
       Suspected EDS 63.3% (n =19) 
Pain Management Use  
       Yes 85.7% (n = 26) 
       No 14.3% (n = 4) 
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3.1.2 Adult Sample 
Subjects were adults (n = 23) between the ages of 18 and 58.  The adult sample consists of male 
(n = 1) and female (n = 22) subjects with an average age of 30.87 (SD ± 12.4) years. These 
participants completed the PQAS©, PedsQLTM QOL suvey, and the Pain Management 
questionnaires.  Sample characteristics including ranges, means, and standard deviations were 
calculated for age, pain, QOL, and pain management amount (Table 4).   
The first set of variables was from the PQAS© pain questionnaire.  The mean total pain 
score was 4.11 (SD ± 1.72), with a mean of 4.14 (SD ± 2.29), 3.56 (SD ± 1.68), and 4.71 (SD ± 
2.19) for paroxysmal pain, surface pain, and deep pain respectively.   The mean score for pain 
severity was 3.3 (SD ± 2.38) for surface pain and 6.61 (SD ± 2.93) for deep pain.  The mean for 
overall pain unpleasantness was 6.39 (SD ± 2.74). 
The next set of variables was from the PedsQLTM QOL questionnaire.  The mean total 
QOL score was 48.44 (SD ± 17.73).  The mean scores for the subscales physical QOL and 
psychosocial QOL were 36.82 (SD ± 24.14) and 53.62 (SD ± 17.69) respectively.  The mean 
scores of the components of psychosocial QOL were 52.39 (SD ± 16.8) for emotional QOL, 
65.65 (SD ± 18.36) for social QOL, and 45.87 (SD ± 16.05) for school/work QOL.  
The total amount of pain management techniques used ranged from 0 to 8, with a mean 
of 3.2 (SD ± 2.27). 
The last variable is from the pain management questionnaire.  The total amount of pain 
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Table 4: Descriptives for age, pain, QOL and pain management amount in adult subjects 
 M (SD) Range 
Age 30.87 (12.4) 18 - 58 
Total Pain 4.11 (1.72) 0 – 6.45 
      Paroxysmal Pain 4.14 (2.29) 0 – 9.2 
      Surface Pain 3.56 (1.68) 0 - 6.4 
      Deep Pain 4.71 (2.19) 0 - 8.6 
      Pain Unpleasantness 6.39 (2.74) 0 - 10 
      Surface Pain Severity 3.3 (2.38) 0 - 8 
      Deep Pain Severity 6.61 (2.93) 0 - 10 
Total QOL 48.44 (17.73) 21.74 – 86.96 
      Physical QOL 36.82 (24.18) 0.13 – 93.75 
      Psychosocial QOL 53.62 (17.69) 23.33 – 90.0 
           Emotional QOL 52.39 (16.8) 20 - 85 
           Social QOL 65.65 (18.36) 20 - 100 
           School/Work QOL 45.87 (26.05) 0 - 85 
Pain Management Amount 3.3 (2.44) 0 - 8 
 
 Sample frequencies were calculated for sex, diagnosis, pain management use, and pain 
classification (Table 5).  The sample population was 95.7% (n = 22) female and 4.3% (n = 1) 
male.  About 30.4% (n = 7) have a confirmed diagnosis of EDS, while 63.3% (n = 16) have a 
suspected EDS diagnosis. Of this sample, 82.6% (n = 19) used some type of pain management.  
About 78.3% (n = 18) reported that their pain was variable on the pain classification question 
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       Female 95.7% (n = 22) 
       Male 4.3% (n = 1) 
Diagnosis 
       Clinical EDS Diagnosis 30.4% (n = 7) 
       Suspected EDS 69.6% (n =16) 
Pain Management Use  
       Yes 82.6% (n = 19) 
       No 17.4% (n = 4) 
 
3.1.3 Child Sample 
Child subjects (n = 7) consist of males (n = 4) and females (n = 3) between the ages of 13 and 18.  
These participants completed the PedsQLTM Pediatric Pain Questionnaire TM, PedsQLTM QOL 
survey, and the Pain Management questionnaire. Sample ranges for the child subjects were 
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Table 6: Ranges for age, pain, QOL and pain management amount in child subjects  
 
 Range 
Age 13 - 17 
Present Pain 0 - 6 
Worst Pain 0 - 10 
Total QOL 35.87 – 83.7 
      Physical QOL 21.88 – 100 
      Psychosocial QOL 43.33 – 78.33 
           Emotional QOL 35 - 80 
           Social QOL 55 - 90 
           School/Work QOL 20 - 90 
Pain Management Amount 0 - 4 
 
The ranges were calculated for sex, pain management use, and diagnosis in the child 
subjects (Table 7).  The sample population had three females and four males.  Of this sample, six 
used some type of pain management, while one did not use any.  A diagnosis was confirmed in 
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Table 7: Frequencies for sex, diagnosis, and pain management use in child subjects 
 
Sex 
       Female n = 4 
       Male n = 3 
Pain Management Use 
       Yes n = 6 
       No n = 1 
Diagnosis 
       Confirmed EDS Diagnosis n = 4 
       Suspected EDS n = 3  
 
3.2 CHARACTERIZATION OF PAIN 
3.2.1 Pain in Adult Subjects 
The PQAS© (Appendix D) asks subjects to report which type of pain best describes their pain.  
Intermittent pain is defined as pain that “comes and goes.”  Variable pain is defined as pain that 
“vary from one moment to the next,” but these individuals are “never pain free.”  Stable pain is 
defined as pain that “does not change that much from one moment to another.”  Participants were 
asked which of these three types best describes the pattern of their pain.  
About 78.3% (n = 18) of the adult subjects reported that their pain was variable, 17.4% (n 
= 4) reported their pain as intermittent, and 4.3% (n = 1) reported pain as stable.  These results 
are summarized in Table 8. 
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Table 8: Pain Classification in Adult Subjects 
Pain Classification  
       Stable 4.3% (n = 1) 
       Variable 78.3% (n = 18) 
       Intermittent 17.4% (n = 4) 
 
3.2.2 Pain in Child Subjects 
The PPQ TM (Appendix D) begins with an open-ended question that allows the participant to 
describe their pain.  The questions states: “What words would you use to describe your pain or 
hurt?” All seven of the child subjects responded. 
One of the themes that emerged in these responses was the description of the pain as 
aching.  One participant responded with “aching” as the description of pain.  Some other 
participants also reported acute and aching pain.  One participant described the pain as: 
 
 “Mostly aching with acute pain in my knees.” 
 
Another participant reported a similar theme of aching pain with additional acute pain in 
certain areas of the body: 
 
“It depends: some days I have pain from indigestion. Some days I have joint pain 
in my knees.  Other days my forehead aches, and sometimes my shins ache from 
poor arch support.” 
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Some subjects reported that pain did not interfere with their lives.  One subject 
reported “none”, while another subject reported that the pain was “unobtrusive.”   
Another subject reported that pain was variable and described pain as: 
 
“Annoying, random, most of the time tolerable.” 
 
One subject was more descriptive in the response section.  This subject said: 
 
“Sometimes my insides feel like they're attacking each other.  When my joints 
dislocate, it's like someone is sawing or stabbing the leg/arm/shoulder etc.  Every 
day is a fight between me and my body.” 
 
The PPQ TM also includes the outline of a human body and asks the subject to 
place an “X” on the drawing in every area that they were currently experiencing pain.  
The results are summarized in Figure 1.  The areas where pain was reported were: knees 
(n = 3), back (n = 3), shoulders (n = 2), stomach (n = 2), head (n = 1), and hands (n = 1). 
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Figure 1: Areas of pain reported in child patients 
3.3 PAIN MANAGEMENT 
3.3.1 Pain Management in All Subjects 
The number of subjects that reported each type of pain management is summarized in Figure 2.  
Physical therapy was used by 18 subjects and was recounted to be most effective by six subjects. 
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Exercise was reportedly used by 16 subjects and was reported to most effective by one subject.  
Pain medication was used by 24 subjects and was stated to be most effective by fourteen 
subjects. Other types of pain management were described by 19 subjects and reported to be most 
effective by ten of those individuals.  The forms of pain management reported under “other” 
were: chiropractor (n = 5), massages (n = 4), rest (n = 4), heat (n = 4), ice/cold (n = 2), stretching 
(n = 2), surgeries (n =2), swimming (n = 2), acupuncture (n = 1), electrical stimulation (n = 1), 
homeopathic medicine (n = 1), injections in joints (n =1), pain counseling (n = 1), 
popping/putting bones in place (n = 1), and vodka (n = 1).  Four subjects reported that they did 
not use any pain management techniques, and six reported that none of the pain management 
techniques they used were effective in treating their pain. 
 
Figure 2: Types of pain management reported in all subjects 
18	   16	  
24	  
19	  
4	  6	   1	  







Physical	  Therapy	   Exercise	   Pain	  Medication	   Other	   None	  Number	  of	  subjects	  that	  reported	  use	  of	  this	  pain	  mangement	  technique	  Number	  of	  subjects	  that	  reported	  this	  as	  the	  best	  technique	  
  27 
3.3.2 Pain Management in Adult Subjects 
The number of adult subjects that reported each type of pain management is summarized in 
Figure 3.  Physical therapy was used by 11 subjects and was recounted to be most effective by 
four subjects. Exercise was used by 16 subjects and reported to be effective by one subject.  Pain 
medication was used by 18 subjects and was stated to be most effective by 11 subjects. Other 
types of pain management were used by 15 subjects and were most effective for nine subjects.  
The forms of pain management reported under “other” were: chiropractor (n = 4), massages (n = 
3), rest (n = 3), heat (n = 3), ice/cold (n = 2), stretching (n = 2), surgeries (n =2), swimming (n = 
2), acupuncture (n = 1), electrical stimulation (n = 1), homeopathic medicine (n = 1), injections 
in joints (n =1), pain counseling (n = 1), popping/putting bones in place (n = 1), and vodka (n = 
1).  Three subjects reported that they did not use any pain management techniques, and five 
reported that none of the pain management techniques used were most effective.  
Figure 3: Types of pain management reported in adult subjects 
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3.3.3 Pain Management in Child Subjects 
The number of child subjects that reported each type of pain management is summarized in 
Figure 4.  Physical therapy was used by five subjects and was stated to be most effective by two 
subjects. Five subjects used exercise, but none of them found it to me the most effective type of 
pain management.  Pain medication was used by six subjects and was reported to be most 
effective by three subjects.  Other types of pain management were used by four subjects, but only 
one subject reported it to be the most effective pain management.  The forms of pain 
management reported under “other” were: chiropractor (n = 1), heat (n = 1), massages (n = 1), 
and rest (n = 1).  One child subject reported that no pain management techniques were used and 











Figure 4: Types of pain management reported in child subjects 
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3.4 NORMALITY 
The assumption of normality for total pain was testing using the Shapiro-Wilk test (SW =0.929, 
df  =23, p  = 0.103).  These results and the Normal Q-Q plot of total pain (Figure 5) suggested 
that normality was reasonable. 
 
Figure 5: Normal Q-Q Plot for Total Pain 
 
The assumption of normality for total QOL was tested using the Shapiro-Wilk test (SW 
=0.959, df = 23, p = 0.434).  These results and the Normal Q-Q plot of total QOL (Figure 6) 
suggested that normality was reasonable. 
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Figure 6: Normal Q-Q Plot for Total QOL 
3.5 PAIN AND QOL IN ADULTS 
Univariate linear regressions were performed to explore which types of pain are predictors of 
QOL.  A model was generated for total QOL, physical QOL, psychosocial QOL, emotional 
QOL, social QOL, and school/work QOL.  Each model included a pain quality variable as a 
predictor. Correlations were also performed to explore the relationships between pain variables 
and QOL variables (Table 9).  
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Table 9: Correlations for pain, QOL, and pain management amount 










Total Pain -0.769** -0.754** -0.712** -0.589** -0.585** -0.492* 0.318 
Paroxysmal Pain -0.664** -0.664** -0.618** -0.468* -0.469* -0.547** 0.432* 
Surface Pain -0.668** -0.621** -0.710** -0.686** -0.668** -0.397 0.181 
Deep Pain -0.631** -0.616** -0.556* -0.472* -0.458* -0.411 0.340 
Pain 
Unpleasantness -0.727** -0.773** -0.458** -0.277 -0.375 -0.374 0.450* 
Surface Pain 
Severity -0.447* -0.398 -0.383 -0.421* -0.218 -0.217 -0.095 
Deep Pain Severity -0.641** -0.744** -0.408** -0.187 -0.316 -0.388 0.513* 
Pain Management 
Amount -0.367 -0.343 -0.355 0.087 -0.451* -0.376 1 
p < 0.05*, p < 0.01** 
3.5.1 Pain and Total QOL 
Univariate linear regressions were performed to explore which types of pain are predictors of 
total QOL (Table 10). All pain quality types were statistically significant predictors of total QOL 
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Table 10: Univariate regression analyses for pain variables in predicting total QOL 
 
Variable β R2 
Total Pain -0.769** 0.591 
      Paroxysmal Pain -0.692** 0.479 
      Surface Pain -0.714** 0.510 
      Deep Pain -0.624** 0.390 
      Pain Unpleasantness -0.628** 0.394 
      Surface Pain Severity -0.394 0.156 
      Deep Pain Severity -0.587** 0.344 
 p < 0.05*, p < 0.01** 
 
3.5.2 Pain and Physical QOL 
Univariate linear regressions were performed to explore which types of pain are predictors of 
physical QOL (Table 11).  All pain quality types were statistically significant predictors of 
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Table 11: Univariate regression analyses for pain variables in predicting physical QOL 
p < 0.05*, p < 0.01** 
 
3.5.3 Pain and Psychosocial QOL 
Univariate linear regressions were performed to explore which types of pain are predictors of 
psychosocial QOL (Table 12).  All pain quality types were statistically significant predictors of 
psychosocial QOL except for surface pain severity and deep pain severity. 
 
 
Variable β R2 
Total Pain -0.754** 0.569 
      Paroxysmal Pain -0.664** 0.441 
      Surface Pain -0.621** 0.386 
      Deep Pain -0.616** 0.379 
      Pain Unpleasantness -0.773** 0.598 
      Surface Pain Severity -0.398 0.159 
      Deep Pain Severity -0.744** 0.554 
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Table 12: Univariate regression analyses for pain variables in predicting psychosocial QOL 
p < 0.05*, p < 0.01** 
 
3.5.4 Pain and Emotional QOL 
Univariate linear regressions were performed to explore which types of pain are predictors of 
emotional QOL (Table 13).  All pain quality types were statistically significant predictors of 
emotional QOL except for deep pain severity and pain unpleasantness. 
 
 
Variable psychosocial β R2 
Total Pain -0.712** 0.508 
      Paroxysmal Pain -0.618** 0.381 
      Surface Pain -0.710** 0.504 
      Deep Pain -0.556** 0.309 
      Pain Unpleasantness -0.458* 0.210 
      Surface Pain Severity -0.383 0.147 
      Deep Pain Severity -0.408 0.166 
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Table 13: Univariate regression analyses for pain variables in predicting emotional QOL 
p < 0.05*, p < 0.01** 
3.5.5 Pain and Social QOL 
Univariate linear regressions were performed to explore which types of pain are predictors of 
social QOL (Table 14).  All pain quality types were statistically significant predictors of social 





Variable  β R2 
Total Pain -0.589** 0.347 
      Paroxysmal Pain -0.468* 0.219 
      Surface Pain -0.686** 0.471 
      Deep Pain -0.472* 0.223 
      Pain Unpleasantness -0.277 0.077 
      Surface Pain Severity -0.421* 0.177 
      Deep Pain Severity -0.187 0.035 
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Table 14: Univariate regression analyses for pain variables in predicting social QOL 
p < 0.05*, p < 0.01** 
 
3.5.6 Pain and School/Work QOL 
Univariate linear regressions were performed to explore which types of pain are predictors of 
school/work QOL (Table 15). The only pain quality type that was a statistically significant 




Variable  β R2 
Total Pain -0.585** 0.342 
      Paroxysmal Pain -0.469* 0.220 
      Surface Pain -0.668** 0.446 
      Deep Pain -0.458* 0.209 
      Pain Unpleasantness -0.375 0.141 
      Surface Pain Severity -0.218 0.047 
      Deep Pain Severity -0.316 0.100 
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Table 15: Univariate regression analyses for pain variables in predicting school/work QOL 
p < 0.05*, p < 0.01** 
3.6 PAIN, QOL, AND PAIN MANAGEMENT USE 
Multiple regression analysis was performed to explore predictors for the outcome of QOL.  A 
model was generated for total QOL, physical QOL, psychosocial QOL, emotional QOL, social 
QOL, and school/work QOL.  Each model included a pain variable and a pain management 
variable had a significant effect on QOL. 
Variable school/work β R2 
Total Pain -0.492* 0.242 
      Paroxysmal Pain -0.547** 0.299 
      Surface Pain -0.397 0.158 
      Deep Pain -0.411 0.169 
      Pain Unpleasantness -0.374 0.140 
      Surface Pain Severity -0.217 0.047 
      Deep Pain Severity -0.388 0.150 
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3.6.1 Pain, Total QOL, and Pain Management Use 
Multiple linear regressions were performed to explore predictors of total QOL and the results are 
summarized in Table 16.  Surface pain severity and pain management amount were both 
statistically significant predictors of total QOL. 
 
Table 16: Multiple regression analyses for predicting total QOL 
Dependent Variable Independent Variables β F - Value R2 
Total QOL Total Pain Pain Management Use 
-0.761** 
-0.027 14.470** 0.591 
 Paroxysmal Pain Pain Management Use 
-0.689** 
-0.011 9.197** 0.479 
 Surface Pain Pain Management Use 
-0.696** 
-0.078 10.634** 0.515 
 Deep Pain Pain Management Use 
-0.610** 
-0.044 6.427** 0.391 
 Pain Unpleasantness Pain Management Use 
-0.610** 
-0.169 7.317** 0.423 
 Surface Pain Severity Pain Management Use 
-0.373 
-0.195 2.391 0.193 
 Deep Pain Severity Pain Management Use 
-0.569** 
-0.180 6.036** 0.376 
 Total Pain Pain Management Amount 
-0.725** 
-0.136 15.462** 0.607 
 Paroxysmal Pain Pain Management Amount 
-0.656** 
-0.083 9.402** 0.485 
 Surface Pain Pain Management Amount 
-0.669** 
-0.245 13.125** 0.568 
 Deep Pain Pain Management Amount 
-0.565** 
-0.174 7.134** 0.416 
 Pain Unpleasantness Pain Management Amount 
-0.581** 
-0.105 6.758** 0.403 
 Surface Pain Severity Pain Management Amount 
-0.433* 
-0.408* 4.710* 0.320 
 Deep Pain Severity Pain Management Amount 
-0.541* 
-0.089 5.388* 0.350 
p < 0.05*, p < 0.01** 
  39 
3.6.2 Pain, Physical QOL, and Pain Management Use 
Multiple linear regressions were performed to explore predictors of physical QOL and the results 
are summarized in Table 17. Both predictors were not statistically significant in any of the 
models.  
 
Table 17: Multiple regression analyses for predicting physical QOL 
Dependent Variable Independent Variables β F - Value R2 
Physical QOL Total Pain Pain Management Use 
-0.798** 
0.159 14.530** 0.592 
 Paroxysmal Pain Pain Management Use 
-0.722** 
0.177 8.821** 0.469 
 Surface Pain Pain Management Use 
-0.641** 
0.086 6.473** 0.393 
 Deep Pain Pain Management Use 
-0.662** 
0.149 6.641** 0.399 
 Pain Unpleasantness Pain Management Use 
-0.776** 
0.027 14.906** 0.598 
 Surface Pain Severity Pain Management Use 
-0.397 
-0.015 1.890 0.159 
 Deep Pain Severity Pain Management Use 
-0.746** 
0.014 12.433** 0.554 
 Total Pain Pain Management Amount 
-0.718** 
-0.115 13.845** 0.581 
 Paroxysmal Pain Pain Management Amount 
-0.634** 
-0.069 8.005** 0.445 
 Surface Pain Pain Management Amount 
-0.578** 
-0.238 7.881** 0.441 
 Deep Pain Pain Management Amount 
-0.564** 
-0.151 6.641** 0.399 
 Pain Unpleasantness Pain Management Amount 
-0.776** 
0.007 14.865** 0.598 
 Surface Pain Severity Pain Management Amount 
-0.435* 
-0.384 4.386* 0.305 
 Deep Pain Severity Pain Management Amount 
-0.771** 
0.053 12.527** 0.556 
p < 0.05*, p < 0.01** 
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3.6.3 Pain, Psychosocial QOL, and Pain Management Use 
Multiple linear regressions were performed to explore predictors of psychosocial QOL and the 
results are summarized in Table 18.  Surface pain severity and pain management amount were 
both statistically significant predictors of psychosocial QOL. 
 
Table 18: Multiple regression analyses for predicting psychosocial QOL 
Dependent Variable Independent Variables β F - Value R2 
Psychosocial QOL Total Pain Pain Management Use 
-0.668** 
-0.163 11.379** 0.532 
 Paroxysmal Pain Pain Management Use 
-0.565** 
-0.162 6.800** 0.405 
 Surface Pain Pain Management Use 
-0.665** 
-0.196 11.735** 0.540 
 Deep Pain Pain Management Use 
-0.497* 
-0.190 5.196* 0.342 
 Pain Unpleasantness Pain Management Use 
-0.426* 
-0.299 4.255* 0.298 
 Surface Pain Severity Pain Management Use 
-0.350 
-0.308 3.165 0.240 
 Deep Pain Severity Pain Management Use 
-0.378 
-0.309 3.529* 0.261 
 Total Pain Pain Management Amount 
-0.667** 
-0.143 11.093** 0.526 
 Paroxysmal Pain Pain Management Amount 
-0.571** 
-0.108 6.419** 0.391 
 Surface Pain Pain Management Amount 
-0.667** 
-0.234 12.552** 0.577 
 Deep Pain Pain Management Amount 
-0.492* 
-0.187 5.160* 0.340 
 Pain Unpleasantness Pain Management Amount 
-0.374 
-0.186 3.119 0.238 
 Surface Pain Severity Pain Management Amount 
-0.421* 
-0.395* 4.314* 0.301 
 Deep Pain Severity Pain Management Amount 
-0.306 
-0.198 2.424 0.195 
 Surface Pain Severity Pain Management Amount 
-0.435* 
-0.384 4.386* 0.305 
 Deep Pain Severity Pain Management Amount 
-0.771** 
0.053 12.527** 0.556 
p < 0.05*, p < 0.01** 
  41 
3.6.4 Pain, Emotional QOL, and Pain Management Use 
Multiple linear regressions were performed to explore predictors of emotional QOL and the 
results are summarized in Table 19. Both predictors were not statistically significant in any of the 
models.  
 
Table 19: Multiple regression analyses for predicting emotional QOL 
Dependent Variable Independent Variables β F - Value R2 
Emotional QOL Total Pain Pain Management Use 
-0.585** 
-0.017 5.237** 0.348 
 Paroxysmal Pain Pain Management Use 
-0.459* 
-0.027 2.817 0.220 
 Surface Pain Pain Management Use 
-0.681** 
-0.024 8.915** 0.471 
 Deep Pain Pain Management Use 
-0.462* 
-0.032 2.885 0.224 
 Pain Unpleasantness Pain Management Use 
-0.261 
-0.148 1.093 0.098 
 Surface Pain Severity Pain Management Use 
-0.407 
-0.133 2.417 0.195 
 Deep Pain Severity Pain Management Use 
-0.171 
-0.160 0.644 0.060 
 Total Pain Pain Management Amount 
-0.686** 
0.305 7.567** 0.431 
 Paroxysmal Pain Pain Management Amount 
-0.622** 
0.355 4.745* 0.322 
 Surface Pain Pain Management Amount 
-0.726** 
0.218 10.694** 0.517 
 Deep Pain Pain Management Amount 
-0.567* 
0.280 4.127* 0.292 
 Pain Unpleasantness Pain Management Amount 
-0.396 
0.265 1.530 0.133 
 Surface Pain Severity Pain Management Amount 
-0.417 
0.047 2.187 0.179 
 Deep Pain Severity Pain Management Amount 
-0.314 
0.248 0.872 0.080 
p < 0.05*, p < 0.01** 
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3.6.5 Pain, Social QOL, and Pain Management Use 
Multiple linear regressions were performed to explore predictors of social QOL and the results 
are summarized in Table 20.  Surface pain and pain management amount were both statistically 
significant predictors of social QOL. 
 
Table 20: Multiple regression analyses for predicting social QOL 
Dependent Variable Independent Variables β F - Value R2 
Social QOL Total Pain Pain Management Use 
-0.533** 
-0.189 6.007** 0.375 
 Paroxysmal Pain Pain Management Use 
-0.403 
-0.203 3.458 0.257 
 Surface Pain Pain Management Use 
-0.624** 
-0.194 9.282** 0.481 
 Deep Pain Pain Management Use 
-0.391 
-0.212 3.332 0.250 
 Pain Unpleasantness Pain Management Use 
-0.343 
-0.297 2.956 0.228 
 Surface Pain Severity Pain Management Use 
-0.183 
-0.315 1.700 0.145 
 Deep Pain Severity Pain Management Use 
-0.286 
-0.307 2.390 0.193 
 Total Pain Pain Management Amount 
-0.491* 
-0.295 7.257** 0.431 
 Paroxysmal Pain Pain Management Amount 
-0.337 
-0.306 4.203* 0.296 
 Surface Pain Pain Management Amount 
-0.606** 
-0.342* 12.651** 0.559 
 Deep Pain Pain Management Amount 
-0.344 
-0.334 4.453* 0.308 
 Pain Unpleasantness Pain Management Amount 
-0.216 
-0.354 3.173 0.241 
 Surface Pain Severity Pain Management Amount 
-0.263 
-0.476* 3.740* 0.272 
 Deep Pain Severity Pain Management Amount 
-0.114 
-0.393 2.711 0.213 
p < 0.05*, p < 0.01** 
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3.6.6 Pain, School/Work QOL, and Pain Management Use 
Multiple linear regressions were performed to explore predictors of school/work QOL and the 
results are summarized in Table 21.  Both predictors were not statistically significant in any of 
the models.  
 
Table 21: Multiple regression analyses for predicting school/work QOL 
Dependent Variable Independent Variables β F - Value R2 
School/Work QOL Total Pain Pain Management Use 
-0.443* 
-0.178 3.727* 0.272 
 Paroxysmal Pain Pain Management Use 
-0.503* 
-0.136 4.612* 0.316 
 Surface Pain Pain Management Use 
-0.348 
-0.221 2.568 0.204 
 Deep Pain Pain Management Use 
-0.352 
-0.189 2.522 0.201 
 Pain Unpleasantness Pain Management Use 
-0.345 
-0.262 2.617 0.207 
 Surface Pain Severity Pain Management Use 
-0.186 
-0.279 1.416 0.124 
 Deep Pain Severity Pain Management Use 
-0.362 
-0.264 2.812 0.141 
 Total Pain Pain Management Amount 
-0.414* 
-0.245 4.202* 0.296 
 Paroxysmal Pain Pain Management Amount 
-0.473* 
-0.172 4.777* 0.323 
 Surface Pain Pain Management Amount 
-0.340 
-0.315 3.400 0.254 
 Deep Pain Pain Management Amount 
-0.320 
-0.267 3.026 0.232 
 Pain Unpleasantness Pain Management Amount 
-0.257 
-0.261 2.408 0.194 
 Surface Pain Severity Pain Management Amount 
-0.255 
-0.401 2.594 0.206 
 Deep Pain Severity Pain Management Amount 
-0.264 
-0.241 2.393 0.193 
p < 0.05*, p < 0.01** 
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3.7 OTHER FACTORS RELATED TO PAIN AND QOL  
Univariate linear regressions were performed to explore which if age, sex, or pain management 
were predictors of QOL in all subjects.  A model was generated for total QOL, physical QOL, 
psychosocial QOL, emotional QOL, social QOL, and school/work QOL.   
3.7.1 Age and QOL 
Univariate linear regressions were performed to explore which if age is a predictor of QOL 
(Table 22).  Age was a statistically significant predictor of physical QOL. 
 
Table 22: Univariate regression analysis for age and QOL 
Dependent Variable Independent Variable β R2 
Total QOL  Age -0.533 0.375 
   Physical QOL Age -0.412* 0.170 
   Psychosocial QOL Age -0.624 0.481 
       Emotional Age -0.391 0.250 
       Social QOL Age -0.343 0.228 
      School/Work QOL Age -0.183 0.145 
      p < 0.05*, p < 0.01** 
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3.7.2 Sex and QOL 
Univariate linear regressions were performed to explore if sex was a predictors of QOL (Table 
23). Sex was not a predictor of QOL. 
 
Table 23: Univariate regression analysis for sex and QOL 
Dependent Variable Independent Variable β R2 
Total QOL  Sex -0.533 0.375 
   Physical QOL Sex  -0.412 0.170 
   Psychosocial QOL Sex -0.624 0.481 
       Emotional Sex -0.391 0.250 
       Social QOL Sex -0.343 0.228 
      School/Work QOL Sex -0.183 0.145 
p < 0.05*, p < 0.01** 
 
3.7.3 Pain Management and QOL 
Amount of pain management techniques used relates to social QOL. To assess the relationship 
between the amount of pain management techniques used and social QOL, linear regression was 
used and the result is shown below in Table 24.  The prediction model was statistically 
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significant F1, 28 = 7.666, p < 0.05, and accounted for about 21.5% percent of the total variance 
(R2 = 0.215) of social QOL.  The more pain management techniques used, the lower the social 
quality of life.  The predictor of pain unpleasantness, β = -0.464, p < 0.05, had a significant 
effect on social QOL.   
 
Table 24: Regression analysis for pain management amount and social QOL 
Variable β 
Pain Management Amount -0.464* 
R2 = 0.215 p < 0.05*, p < 0.01** 
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4.0  DISCUSSION 
4.1 AIM 1: CHARACTERIZATION OF PAIN IN EDS AND UCTD 
Looking at the subjects in the current study, there were many differences in the pain reported.  
There was a wide variability of types and severity of pain reported across this small and possibly 
unrepresentative sample.   
In the adult population, the scores for all pain qualities had large ranges with some 
subjects reporting pain as low as zero and some reporting pain as high as ten.  The average pain 
scores were highest for pain unpleasantness and deep pain severity.   The majority of adult 
subjects (78.3%) reported that their pain was variable, which is defined as pain that varies in type 
and severity, but is constant [31].  This report confirms previous findings in the literature that a 
large majority of individuals with EDS experience chronic pain that varies in degree [14] 
In the child population, the scores for present pain ranged from zero to six and scores for 
worst pain ranged from zero to ten.  The areas where pain was reported in the children also 
varied.  Three subjects reported pain in their knees and three reported pain in their back.  Two 
participants also labeled the shoulders and stomach as areas where pain was experienced.  One 
subject reported to have pain in the head and hands.  Previous literature has reported that the 
most frequent localization of pain was the neck, hips, shoulders, forearms, and legs, whereas 
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abdominal pain and headaches were reported much more infrequently [14].  The results of this 
study differ, however the earlier studies only included adults with EDS. 
The open-ended question from the child pain survey also revealed more descriptive 
qualities of pain.  There was a theme in the responses of  “aching” pain and “acute” pain.  Also, 
some participants referred to pain as “annoying”, but “most of the time tolerable.”  Some 
respondents answered with “none” or described pain as “unobtrusive.”  On the other hand, one 
participant described pain in much more detail and expressed that the pain was more severe than 
the other subjects.  This participant reported that: “my insides feel like they’re attacking each 
other.”  The subject also reported joint dislocations and that this process feels as if “someone is 
sawing or stabbing” the joint.  The subject concluded the response by saying that “every day is a 
fight between me and my body.”  This last statement implies a considerably decreased quality of 
life.  Some of the previous literature has included similar pain themes, such as cutting, nagging, 
tiring, troublesome, sickening [14]. 
There is pain reported across this small sample, with type and severity fluctuating 
between individuals.  Some individuals reported experiencing no pain, while others clearly had 
severe pain that affected their quality of life.  In this sample, the findings suggest that individuals 
with EDS and UCTD experience wide variability in the type and severity of their pain. 
4.2 AIM 2: PAIN MANAGEMENT USED IN EDS AND UCTD 
Pain management was commonly used in this sample, with the type of techniques used differing 
greatly across the entire sample. 
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The majority (85.7%) of the entire sample reported using some type of pain management.  
First, 24 (80%) subjects reported the use of pain medication, which was the most reported 
response.  Most of those individuals (14) indicated that pain medication was the most effective 
treatment.  This confirms previous literature that reported that pain medication was used by 
about 89% of the individuals with EDS surveyed [14]. Interestingly, there were 16 reports of 
exercise as a pain management technique, however only one subject reported exercise to be the 
most effective technique.  
Of the management that the subjects reported under “other”, the most popular choice was 
going to a chiropractor for manipulation (5), followed by massage (4), rest (4), heat (4), cold (2), 
stretching (2), surgeries (2), and swimming (2).  Only one individual reported the use of each of 
the following management: acupuncture, electrical stimulation, homeopathic medicine, 
injections in joints, pain counseling, putting bones back in place, and vodka.  Interestingly 
enough, only one person reported the use of controlled substances.  This may be because the 
individuals did not want to report the use of controlled or illegal drugs for the purposes of this 
study.   
These results are similar to those reported in the literature for other chronic pain 
syndromes.  A previous study has reported that pain medication, rest, heat, and exercise were the 
methods used most by individuals with rheumatoid arthritis [36].  The most helpful were pain 
medication, rest and heat [36].   However, the number of pain management techniques used was 
increased in younger individuals with rheumatoid arthritis, which is not something that was 
noted in this study [36].  This may be explained by the differences in the natural history of the 
two conditions.  
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Pain management use is reported across this small sample, with the type of technique 
used widely varying between individuals.  The findings from this sample suggest that individuals 
with EDS and UCTD may use many different techniques to manage their pain.  The findings also 
suggest that exercise may not be effective for most of these individuals, however further study 
with a larger sample is needed to confirm. 
4.3 AIM 3: RELATIONSHIP BETWEEN PAIN AND QOL  
As expected, this study indicates that increased pain is very strongly associated with decreased 
quality of life in this population.  Almost every pain quality was a statistically significant 
predictor of quality of life.  This confirms the data found from previous studies that indicated this 
relationship exists when there is chronic pain in EDS populations and other chronic pain 
syndromes [6, 21, 37, 38]. 
Another related finding was that increased amount of pain management techniques used 
and increased surface pain had a statistically significant effect on social QOL. This relationship 
was not identified in any other type of pain or QOL.  A possible explanation is that pain 
management is less effective for treating surface pain, therefore these individuals must use more 
pain management techniques to help relieve their discomfort. Potentially, pain management may 
be more effective at treating the other types of pain in this population (such as deep pain), since 
it does not appear to be suitable for relieving surface pain. This relationship does not exist with 
any of the other types of pain or subscales of quality of life. 
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4.4 AIM 4: RELATIONSHIPS OF OTHER FACTORS WITH QOL 
One interesting finding was the statistically significant relationship between increased amounts 
of pain management techniques and decreased social quality of life in this sample.  One potential 
explanation for this relationship is that more pain management may interfere with a person’s 
daily life and logically could decrease a person’s social QOL.  Another possible explanation is 
that those who use more pain management techniques may have more severe pain, which would 
then impact their social lives and decrease their social QOL.  Those who use more pain 
management techniques have significantly increased pain unpleasantness and deep pain severity.  
This could indicate an increased need for social support in individuals with EDS and UCTD 
Age was also found to be a statically significant predicator of physical QOL in the entire 
sample.  This result supports the claims in previous literature that the physical nature of this 
disease becomes more severe with age. [6] 
Sex was not found to be a significant predictor of QOL.  This may be explained by the 
small sample of males in the current study. 
4.5 IMPLICATIONS FOR EDS AND UCTD 
The main aim of this study was to assess the relationship between pain and quality of life in EDS 
and UCTD patients.  By establishing this association, the effectiveness of pain management 
techniques can be analyzed to determine if they change the relationship.   Determining which 
pain management techniques are most effective could help healthcare professionals to better 
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treat, manage, and possibly prevent the chronic pain that these individuals experience.  Reducing 
or relieving pain in these individuals would hopefully increase their quality of life. 
4.6 PUBLIC HEALTH SIGNIFICANCE 
Since EDS and UCTD are not well-known conditions, there is very limited public knowledge 
about these conditions, even in the medical field.  Many people have symptoms of connective 
tissue disorders, but may not know enough to seek an evaluation for these conditions.   Clinical 
diagnosis is also subjective and may depend on the physician diagnosing the condition. 
Furthermore, many individuals with a clinical diagnosis of EDS are not able to confirm a 
diagnosis through molecular testing. Thus, connective tissue disorders often go undiagnosed 
much longer than other conditions due to these issues. 
This study could also serve as a template for other conditions that involve chronic pain 
and decreased quality of life.  If pain management techniques or other interventions could be 
implemented, this could vastly improve the quality of life in people who suffer from debilitating 
and disabling conditions. 
4.7  LIMITATIONS 
One limitation of this study was the small sample size of participants.  The survey was sent to 
125 patients and 30 surveys were returned.  The study could have been much stronger if there 
were more participants, especially if there are more subtle relationships among the variables.  
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Having a few outliers could significantly alter the results of the study because there were a 
modest number of participants.   
This may be another explanation as to why there were no significant findings for some 
variables.  If there were a larger group of children and adults that participated, perhaps the 
relationships found would have been stronger and more relationships would have been 
statistically significant.  At the same time, it should be noted that in the prior literature of EDS 
and UCTD patients, it is not uncommon to have group sizes as small as or smaller than the 30 
participants in this study [6, 12, 16, 21, 37]. 
Another limitation is that the participants either have a clinical diagnosis of EDS that has 
not been confirmed genetically, or they have UCTD that is suspected to be EDS.  The physician 
and healthcare providers that evaluate this patient in the genetics clinic make the distinction in 
diagnoses.   This diagnosis can be subjective in determining if someone has a diagnosis of EDS 
or has some type of UCTD, but the type cannot always be determined by their symptoms due to 
the overlap in EDS types.  This physician bias may also affect the results of this study. 
Another limitation of this study is that we were unable to compare the children to the 
adults because different surveys were used.  The PQAS© questionnaire used for adults was more 
complicated to allow for more descriptive and specific data.   The PQAS© would likely be too 
confusing and advanced for most children to answer.  The child pain surveys were much simpler 
and were targeted towards the age groups.   One potential idea would be to give a simple pain 
survey to both adults and child patients.  However, if the adults had received a much simpler 
survey, the more subtle relationships between certain pain qualities would be lost.  If the same 
survey were to be used, the data would likely be limited to pain severity, frequency, and location.  
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Another limitation is the number of surveys received for the pediatric population.  Only 6 
were returned which did not give us enough data to analyze the relationships in the pediatric 
population.  Potential explanations for this are that the pediatric patients are experiencing less 
pain than the adult populations.  Also, the surveys of those under 18 were sent to the parents, so 
it is possible that the parents were not as motivated for their child to participate in this study. 
Only one adult male returned the survey for the current study.  This may be explained by 
the fact that of the 69 adults that were eligible for the study, only 14 of those were male.  This is 
not an uncommon finding in previous studies as the majority of individuals with EDS are 
reportedly female, sometimes over 90% [6, 12, 14].   It is also possible that men in this 
population do not participate in research as much as females because they are not seeking a 
diagnosis or medical assistance.  Potentially, the condition may affect them differently and they 
are not as motivated to seek medical help or a diagnosis. 
4.8 FUTURE RESEARCH 
The data in this study provided some information about pain, quality of life, and pain 
management in patients with EDS and UCTD.  However, future research on CTD and pain 
would be beneficial to these patients.   
 It would be valuable to consider a longitudinal study of EDS or other CTD patients to 
determine if the relationship between pain and QOL changes over the lifetime.  It would also be 
interesting to do studies on individuals before and after they have begun a type of pain 
management to determine more directly if their quality of life is improving.  Additional variables 
could be evaluated to determine if there are any other factors that affect these relationships such 
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as the number of symptomatic years or number of dislocation events.  Also, using genetic testing 
as a variable could be beneficial in determining if there are any genotype/phenotype correlations. 
Another possible direction would be to change the way the data was collected.  Very few 
surveys were sent back from the pediatric population compared to the adult population.  A future 
study could involve in-person interviews or collecting the data verbally when a child presents to 
the clinic with EDS or UCTD.  This would increase the response rate and increase the sample 
size. 
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APPENDIX A 
IRB APRROVAL LETTER 
 
To: Suneeta Madan-Khetarpal MD 
From: Christopher Ryan PHD, Vice Chair 
Date: 2/3/2014  
IRB#: PRO13080515 
Subject: Pain and quality of life in connective tissue disorder patients  
 
The University of Pittsburgh Institutional Review Board reviewed and approved the 
above referenced study by the expedited review procedure authorized under 45 CFR 46.110 and 
21 CFR 56.110.  Your research study was approved under: 
45 CFR 46.110.(5) 
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45 CFR 46.110.(7) 
 
 
The risk level designation is Minimal Risk. 
Approval Date: 2/3/2014 
Expiration Date: 2/2/2015 
For studies being conducted in UPMC facilities, no clinical activities can be undertaken 
by investigators until they have received approval from the UPMC Fiscal Review Office. 
Please note that it is the investigator’s responsibility to report to the IRB any 
unanticipated problems involving risks to subjects or others [see 45 CFR 46.103(b)(5) and 21 
CFR 56.108(b)]. Refer to the IRB Policy and Procedure Manual regarding the reporting 
requirements for unanticipated problems, which include, but are not limited to, adverse 
events.  If you have any questions about this process, please contact the Adverse Events 
Coordinator at 412-383-1480. 
The protocol and consent forms, along with a brief progress report must be resubmitted at 
least one month prior to the renewal date noted above as required by FWA00006790 (University 
of Pittsburgh), FWA00006735 (University of Pittsburgh Medical Center), FWA00000600 
(Children’s Hospital of Pittsburgh), FWA00003567 (Magee-Womens Health Corporation), 
FWA00003338 (University of Pittsburgh Medical Center Cancer Institute). 
Please be advised that your research study may be audited periodically by the 
University of Pittsburgh Research Conduct and Compliance Office. 
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Copyright © Galer, Jensen & Gammaitoni, 2003, All Rights Reserved. 
 
PQAS-19 - United States/English 
PQAS_AU3.0_eng-USori.doc 
PAIN QUALITY ASSESSMENT SCALE©  (PQAS©) 
 
Instructions:  There are different aspects and types of pain that patients experience and that we 
are interested in measuring.  Pain can feel sharp, hot, cold, dull, and achy.  Some pains may feel 
like they are very superficial (at skin-level), or they may feel like they are from deep inside your 
body.  Pain can also be described as unpleasant. 
 
The Pain Quality Assessment Scale helps us measure these and other different aspects of your 
pain.  For one patient, a pain might feel extremely hot and burning, but not at all dull, while another 
patient may not experience any burning pain, but feel like their pain is very dull and achy.  
Therefore, we expect you to rate very high on some of the scales below and very low on others.   
 
Please use the 19 rating scales below to rate how much of each different pain quality and type you 
may or may not have felt OVER THE PAST WEEK, ON AVERAGE.  
 
Place an “X” through the number that best describes your pain. For example: 
  ...0   |   1   |   2   |   3   |   4   |   5   |   6   |   7   |   8   |   9   |   10...  
 
1.  Please use the scale below to tell us how intense your pain has been over the past week, on 
average. 
    
 No  
pain ...0   |   1   |   2   |   3   |   4   |   5   |   6   |   7   |   8   |   9   |   10... 
The most intense  
pain sensation 
imaginable 
2.  Please use the scale below to tell us how sharp your pain has felt over the past week.  Words used 
to describe sharp feelings include “like a knife”, “like a spike”, or “piercing”. 
    
 Not  
sharp  ...0   |   1   |   2   |   3   |   4   |   5   |   6   |   7   |   8   |   9   |   10... 
The most sharp 
sensation imaginable 
(“like a knife”) 
3.  Please use the scale below to tell us how hot your pain has felt over the past week.  Words used to 
describe very hot pain include “burning” and “on fire”. 
    
 Not  
hot  ...0   |   1   |   2   |   3   |   4   |   5   |   6   |   7   |   8   |   9   |   10... 
The most hot 
sensation imaginable 
(“burning”) 
4.  Please use the scale below to tell us how dull your pain has felt over the past week. 
    
 Not  
dull  ...0   |   1   |   2   |   3   |   4   |   5   |   6   |   7   |   8   |   9   |   10... 
The most dull 
sensation imaginable 
5.  Please use the scale below to tell us how cold your pain has felt over the past week.  Words used to 
describe very cold pain include “like ice” and “freezing”. 
    
 Not  
cold  ...0   |   1   |   2   |   3   |   4   |   5   |   6   |   7   |   8   |   9   |   10... 




  67 
 
6.  Please use the scale below to tell us how sensitive your skin has been to light touch or clothing 
rubbing against it over the past week.  Words used to describe sensitive skin include “like sunburned 
skin” and “raw skin”. 
    
 Not 
sensitive  ...0   |   1   |   2   |   3   |   4   |   5   |   6   |   7   |   8   |   9   |   10... 
The most sensitive 
sensation imaginable 
(“raw skin”) 
7.  Please use the scale below to tell us how tender your pain is when something has pressed against 
it over the past week.  Another word used to describe tender pain is “like a bruise”. 
    
 Not  
tender  ...0   |   1   |   2   |   3   |   4   |   5   |   6   |   7   |   8   |   9   |   10... 
The most tender 
sensation imaginable 
(“like a bruise”) 
8.  Please use the scale below to tell us how itchy your pain has felt over the past week.  Words used 
to describe itchy pain include “like poison ivy” and “like a mosquito bite”. 
    
 Not  
itchy  ...0   |   1   |   2   |   3   |   4   |   5   |   6   |   7   |   8   |   9   |   10... 
The most itchy 
sensation imaginable 
(“like poison ivy”) 
9.  Please use the scale below to tell us how much your pain has felt like it has been shooting over the 
past week.  Another word used to describe shooting pain is “zapping”. 
    
 Not 
shooting  ...0   |   1   |   2   |   3   |   4   |   5   |   6   |   7   |   8   |   9   |   10... 
The most shooting 
sensation imaginable 
(“zapping”) 
10.  Please use the scale below to tell us how numb your pain has felt over the past week.  A phrase 
that can be used to describe numb pain is "like it is asleep”. 
    
 Not  
numb  ...0   |   1   |   2   |   3   |   4   |   5   |   6   |   7   |   8   |   9   |   10... 
The most numb 
sensation imaginable 
(“asleep”) 
11.  Please use the scale below to tell us how much your pain sensations have felt electrical over the 
past week.  Words used to describe electrical pain include “shocks”, “lightning”, and “sparking”. 
    
 Not 
electrical  ...0   |   1   |   2   |   3   |   4   |   5   |   6   |   7   |   8   |   9   |   10... 
The most electrical 
sensation imaginable 
(“shocks”) 
12.  Please use the scale below to tell us how tingling your pain has felt over the past week.  Words 
used to describe tingling pain include “like pins and needles” and “prickling”. 
    
 Not  
tingling  ...0   |   1   |   2   |   3   |   4   |   5   |   6   |   7   |   8   |   9   |   10... 
The most tingling 
sensation imaginable 
(“pins and needles”) 
13.  Please use the scale below to tell us how cramping your pain has felt over the past week.  Words 
used to describe cramping pain include “squeezing” and “tight”. 
    
 Not 
cramping  ...0   |   1   |   2   |   3   |   4   |   5   |   6   |   7   |   8   |   9   |   10... 
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14.  Please use the scale below to tell us how radiating your pain has felt over the past week.  Another 
word used to describe radiating pain is “spreading”. 
    
 Not 
radiating  ...0   |   1   |   2   |   3   |   4   |   5   |   6   |   7   |   8   |   9   |   10... 
The most radiating 
sensation imaginable 
(“spreading”) 
15.  Please use the scale below to tell us how throbbing your pain has felt over the past week.  
Another word used to describe throbbing pain is “pounding”. 
    
 Not 
throbbing  ...0   |   1   |   2   |   3   |   4   |   5   |   6   |   7   |   8   |   9   |   10... 
The most throbbing 
sensation imaginable 
(“pounding”) 
16.  Please use the scale below to tell us how aching your pain has felt over the past week.  Another 
word used to describe aching pain is “like a toothache”. 
    
 Not aching  
...0   |   1   |   2   |   3   |   4   |   5   |   6   |   7   |   8   |   9   |   10... 
The most aching 
sensation imaginable 
(“like a toothache”) 
17.  Please use the scale below to tell us how heavy your pain has felt over the past week.  Other 
words used to describe heavy pain are “pressure” and “weighted down”. 
    
 Not  
heavy  ...0   |   1   |   2   |   3   |   4   |   5   |   6   |   7   |   8   |   9   |   10... 
The most heavy 
sensation imaginable 
(“weighted down”) 
18.  Now that you have told us the different types of pain sensations you have felt, we want you to tell 
us overall how unpleasant your pain has been to you over the past week.  Words used to describe 
very unpleasant pain include “annoying,” “bothersome,” “miserable,” and “intolerable”.  Remember, pain 
can have a low intensity but still feel extremely unpleasant, and some kinds of pain can have a high 
intensity but be very tolerable.  With this scale, please tell us how unpleasant your pain feels. 
    
 Not 
unpleasant  ...0   |   1   |   2   |   3   |   4   |   5   |   6   |   7   |   8   |   9   |   10... 
The most unpleasant 
sensation imaginable 
(“intolerable”) 
19.  Finally, we want you to give us an estimate of the severity of your deep versus surface pain over 
the past week.  We want you to rate each location of pain separately.  We realize that it can be difficult 
to make these estimates, and most likely it will be a “best guess,” but please give us your best estimate. 
 HOW INTENSE IS YOUR DEEP PAIN? 
    
 No  
deep  
pain  
...0   |   1   |   2   |   3   |   4   |   5   |   6   |   7   |   8   |   9   |   10... 
The most intense 
deep pain sensation 
imaginable 
    
 HOW INTENSE IS YOUR SURFACE PAIN? 
 No  
surface  
pain  
...0   |   1   |   2   |   3   |   4   |   5   |   6   |   7   |   8   |   9   |   10... 
The most intense 
surface pain sensation 
imaginable 
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20. Pain can also have different time qualities.  For some people, the pain comes and goes and so they 
have some moments that are completely without pain; in other words the pain “comes and goes”.  
This is called intermittent pain.  Others are never pain free, but their pain types and pain severity 
can vary from one moment to the next.  This is called variable pain.  For these people, the 
increases can be severe, so that they feel they have moments of very intense pain (“breakthrough” 
pain), but at other times they can feel lower levels of pain (“background” pain).  Still, they are never 
pain free.  Other people have pain that really does not change that much from one moment to 
another.  This is called stable pain.  Which of these best describes the time pattern of your pain 
(please select only one): 
  
 (  ) I have intermittent pain (I feel pain sometimes but I am pain-free at other times). 
 (  ) I have variable pain (“background” pain all the time, but also moments of more pain, or even 
severe “breakthrough pain or varying types of pain). 
 (  ) I have stable pain (constant pain that does not change very much from one moment to another, 
and no pain-free periods). 
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